Sahajanand Medical Technologies’ (SMT) TAVR product Hydra’s 5-year follow-up results from the pivotal Hydra CE Study were presented by Dr. Vilhelmas Bajoras at PCR London Valves 2025. The long-term data reaffirm Hydra’s durable valve performance, sustained hemodynamic improvement, and favourable safety profile in patients with
In a pioneering step for India’s biotechnology and precision medicine landscape, the Indian Institute of Technology Madras (IIT-Madras), in collaboration with the Indian Railway Finance Corporation (IRFC), has established the country’s first Single Cell Omics Translational Research Laboratory. The state-of-the-art facility aims to accelerate breakthroughs
Manipal Hospitals Bengaluru has strengthened its liver care program with an expanded multidisciplinary team, bringing advanced expertise in surgery, hepatology, and perioperative care. Based at the Old Airport Road unit, the team will lead advancements in liver disease management, complex hepatobiliary surgeries, and transplant services, while extending specialized support
In a major move to strengthen pediatric healthcare, the Tamil Nadu government has announced the statewide expansion of Type 1 diabetes care for children across all government hospitals. The initiative, unveiled by the state’s Health Minister, aims to ensure early diagnosis, uninterrupted treatment, and long-term
National Health Authority (NHA) has renewed its Memorandum of Understanding (MoU) with the Department of Health Research (DHR) and the Indian Council of Medical Research (ICMR) to promote evidence-based healthcare delivery under the flagship health programs Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and
Aster Whitefield implemented the state-of-the-art technology for cancer treatment last year and is India’s only hospital offering IOeRT, completing 140+ procedures with proven clinical success in a year. Radiation delivered during surgery ensures higher precision, faster recovery, and minimal damage to healthy tissue. Clinical
In a significant step towards promoting mental well-being at workplaces, Infosys, in collaboration with the National Institute of Mental Health and Neurosciences (NIMHANS), has launched a comprehensive Mental Health Training Manual aimed at strengthening employee wellness programs across corporate India. The manual, designed jointly by experts
In a significant medical advancement, researchers at a Gurugram-based institute have reported a major breakthrough in the treatment of children suffering from Sickle Cell Disease (SCD), a genetic blood disorder that affects the shape and function of red blood cells. The institute’s clinical research team has
Dementia India Alliance (DIA), a national, NGO dedicated to promoting awareness, advocacy, and care for people living with dementia, and Apollo AyurVAID Hospitals, India’s leading Precision Ayurveda hospital network under the Apollo Hospitals Group, have joined hands to advance integrative dementia care and awareness in
Second quarter revenue from operations grows 4% sequentially and 2% year-on-year to Rs. 911 Cr 1st half revenue from operations up 6% Syngene International Limited today announced financial results for the second quarter and half year of FY26. Quarterly Financial Highlights (All numbers are in Indian Rupees in Cr except margins) Q2 FY25 Q2 FY26 YoY Change (%) Revenue from Operations 891 911 2% Reported Revenue 908 926 2% Reported EBITDA 261 215 -18% Reported EBITDA margin (%) 28.8% 23.2% Reported PAT (before exceptional items) 106 67 -37% Reported PAT Margin (%) 11.7% 7.3% H1 FY26 Financial Highlights (All numbers are in Indian rupees in Crores except margins) H1 FY25 H1 FY26 YoY Change (%) Revenue from Operations 1,681 1,785 6% Reported Revenue 1,715 1,818 6% Reported EBITDA 449 439 -2% Reported EBITDA margin (%) 26.2% 24.1% Reported PAT (before exceptional items) 161* 154 -4% Reported PAT Margin (%) 9.4% 8.5% Excludes exceptional item of Rs. 21 crores (net of tax) in Q1 FY25 relating to final settlement from an insurance claim. Commenting on the results, Peter Bains, Managing Director and CEO, Syngene International Limited, said, “Our Q2 performance was driven by underlying revenue growth from research
